top of page
Search


Jun 9, 20224 min read
Antisense Therapeutics - a purpose driven biotech with global potential
It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...
361 views0 comments


May 2, 20214 min read
Recce Pharmaceuticals Limited – A revolution in development of treating superbugs
Recce Pharmaceuticals (ASX: RCE: FSE: R9Q) is a global leader in the new generation of anti-infective therapies. The company is listed on...
207 views0 comments


Jan 8, 20212 min read
Antisense shares have increased by 60% after Sarepta results
Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...
1,000 views0 comments


Dec 30, 20205 min read
mRNA and Antisense biotech - attracting the large fund managers and defining 2020
As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...
3,803 views0 comments


Dec 9, 20203 min read
Ionis Pharmaceuticals - A force for life
RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...
510 views0 comments


Nov 26, 20202 min read
Antisense Therapeutics Limited dual-lists in Europe
An exciting and innovative Australian biotech - Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) has now listed on the Frankfurt...
120 views0 comments
bottom of page